Fig. 6From: Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPDPlasma concentration of abediterol over time (PK population). Data reported as mean ± SD. PK, pharmacokinetic; SD, standard deviationBack to article page